NCT02135887 2020-12-22
MB-6
Microbio Co Ltd
Unknown
Clinical Trials
6 trialsNCT02544685 2019-01-17
FENSY
S&D Pharma SK s.r.o.
Phase 2 Unknown
NCT03404752 2018-01-19
Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
Gema Biotech S.A.
Phase 3 Unknown
NCT02725606 2017-08-18
Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer
Jiangsu T-Mab Biopharma Co.,Ltd
Phase 1 Unknown
NCT01560195 2012-11-06
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT00501332 2007-12-24
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Maxygen Holdings Ltd.
Phase 2 Unknown